HMOX2 and acute lymphoblastic leukemia: WT1 loss in T-ALL impairs transcriptional activation of TP53 and elevates pro-survival genes BIRC5 (survivin), XIAP, and HMOX2 (HO-2) following DNA damage, thereby promoting leukemic cell survival and treatment resistance [85].